21 September 2016 - U.S. lawmakers have today blasted steep price increases for Mylan's EpiPen emergency allergy treatment as they grilled the company's Chief Executive Heather Bresch at a congressional hearing.

The House Committee on Oversight and Government Reform called Bresch to testify after the company raised the list price for a pair of EpiPen injections to $600 compared with $100 in 2007, when it acquired the product.

Democratic Congressman Elijah Cummings said Mylan "jacked up" the price of the life-saving product "to get filthy rich at the expense of our constituents."

"After Mylan takes our punches they'll fly back to their mansions in their private jets and laugh all the way to the bank," Cummings said.

Read Reuters article